Search

Your search keyword '"Moore, Malcolm J."' showing total 546 results

Search Constraints

Start Over You searched for: Author "Moore, Malcolm J." Remove constraint Author: "Moore, Malcolm J."
546 results on '"Moore, Malcolm J."'

Search Results

1. Data from Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

2. Supplementary Data 1 from Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

3. The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17.

4. Characterizing the genomic landscape of locally advanced pancreatic cancer.

5. Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials

7. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

9. Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

10. Latency and interval therapy affect the evolution in metastatic colorectal cancer

11. Vascular resection for pancreas cancer: Ten-year real-world experience from a single high-volume center.

12. Figure S6 from Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer

13. Data from Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial

14. Online Supplementary Materials from Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial

16. Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

17. Predictive and prognostic features of metastatic colorectal cancer arising from the transverse colon: A pooled analysis of the CCTG/AGITG CO.17 and CO.20 randomized trials.

18. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

19. Combined burden and functional impact tests for cancer driver discovery using DriverPower

20. Integrative pathway enrichment analysis of multivariate omics data

21. Pathway and network analysis of more than 2500 whole cancer genomes

22. Divergent mutational processes distinguish hypoxic and normoxic tumours

23. Genomic footprints of activated telomere maintenance mechanisms in cancer

24. Evaluating the time toxicity of cancer treatment in the CCTG CO.17 randomized clinical trial (RCT).

25. Prospective Evaluation of Acute Toxicity and Quality of Life After IMRT and Concurrent Chemotherapy for Anal Canal and Perianal Cancer

29. Pancreatic Adenocarcinoma Surveillance Counterpoint: Canada

31. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

33. A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

35. Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

45. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection

46. Quality of Life in Patients With K-RAS Wild-Type Colorectal Cancer: The Co.20 Phase 3 Randomized Trial

48. K-ras mutations and benefit from cetuximab in advanced colorectal cancer

Catalog

Books, media, physical & digital resources